Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Outsourcing No Longer Just for Cost-Cutting

June 2, 2014

Pharmaceutical Technology

With budgets growing, clients see CMOs' costs as less crucial.

India's Developing Market Offers Opportunities

May 2, 2014

Pharmaceutical Technology

Biopharma companies should not overlook India's growing market.

Stuck in Neutral

May 2, 2014

Pharmaceutical Technology

The CMO industry's value proposition is limiting its market penetration.

Biopharma Outsourcing Activities Update

April 2, 2014

Pharmaceutical Technology

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

Drug Discovery Partnerships between UK CROs and the Swiss Pharma Sector

April 2, 2014

Pharmaceutical Technology

The international pharmaceutical industry is changing its approach to R&D and is increasingly relying on outsourcing for drug discovery.

Under New Ownership

March 2, 2014

Pharmaceutical Technology

Changes in company ownership shake up the CMO industry.

What is Quality by Design (QbD) – and Why Should You Care?

February 26, 2014

Is your development or manufacturing operation experiencing cost over-runs and unproductive delays? Do you want to optimize your development dollars and ensure a robust commercial process? You are not alone.

FDA Initiates Secure Supply Chain Pilot Program

February 18, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

Thirteen companies are accepted for participation in the supply chain program.

Novel Expression Systems Opening CMO Opportunities

February 2, 2014

Pharmaceutical Technology

CMOs may find opportunities in alternative expression services.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here